Doctor explaining CBD diagnosis using abdominal imaging and diagnostic tests to patients
CBD's symptoms substantially overlap with several other conditions, particularly Progressive Supranuclear Palsy, Parkinson's disease, and Dementia with Lewy Bodies. Because of this overlap, diagnosis relies heavily on recognizing a specific combination and pattern of features over time, rather than any single defining test result.

Medically reviewed by Dr. Mitesh Chandarana | Last updated: September 2026

Corticobasal Degeneration (CBD) is widely recognized as one of the most challenging movement disorders to diagnose accurately. Unlike more common conditions, there’s no single blood test or scan that can confirm CBD on its own – in fact, a fully definitive diagnosis technically requires brain tissue examination after death. In practice, however, neurologists use a structured combination of clinical assessment and testing to reach a confident diagnosis during a patient’s lifetime, which is what this guide walks through.

(For a general overview of CBD symptoms and treatment, see our Corticobasal Degeneration overview. This piece focuses specifically on the diagnostic process.)

Why CBD Is Difficult to Diagnose

CBD’s symptoms substantially overlap with several other conditions, particularly Progressive Supranuclear Palsy, Parkinson’s disease, and Dementia with Lewy Bodies. Because of this overlap, diagnosis relies heavily on recognizing a specific combination and pattern of features over time, rather than any single defining test result.

Step 1: Detailed Clinical History and Examination

This remains the foundation of CBD diagnosis. Key features I look for include:

  • Asymmetric onset – CBD characteristically begins on one side of the body, often one hand or arm, more so than typical Parkinson’s disease
  • Limb apraxia – difficulty performing purposeful, learned movements despite normal muscle strength, such as trouble using a familiar tool
  • Alien limb phenomenon – a distinctive and specific feature where a limb, usually an arm, seems to move involuntarily or act independently of conscious control
  • Cortical sensory loss – difficulty recognizing objects by touch alone, or difficulty perceiving where on the body a stimulus is applied
  • Rigidity and dystonia in the affected limb, often not responding well to standard Parkinson’s medication
  • Cognitive changes – particularly difficulties with planning, language, or behaviour, which can occur alongside or sometimes precede the movement symptoms

In my practice, the combination of markedly asymmetric symptoms, apraxia, and a limb that responds poorly to levodopa is often what first raises suspicion for CBD rather than typical Parkinson’s disease – this pattern recognition, built from clinical experience, remains central to diagnosis even with modern imaging available.

Step 2: Brain Imaging (MRI)

MRI doesn’t provide a definitive yes/no answer for CBD, but it plays an important supportive role:

  • Asymmetric brain atrophy – CBD often shows more pronounced shrinkage on one side of the brain, corresponding to the side of the body with more severe symptoms
  • Specific regions affected – atrophy is often most notable in the parietal and frontal cortex regions, distinct from the brainstem-predominant patterns seen in PSP or the cerebellar patterns seen in MSA
  • Ruling out other causes – MRI also helps exclude structural causes like stroke or tumor that could mimic CBD’s asymmetric presentation

(For a general guide to understanding MRI terminology, see How to Read Your MRI Report.)

Step 3: Neuropsychological Testing

Given how often cognitive and behavioral changes appear in CBD, sometimes even before movement symptoms are prominent, formal neuropsychological testing helps:

  • Document specific patterns of cognitive difficulty (executive function, language, apraxia testing)
  • Distinguish CBD’s cognitive profile from other conditions like Alzheimer’s disease or frontotemporal dementia, which can have overlapping features
  • Establish a baseline for monitoring changes over time

Step 4: Ruling Out Other Conditions

Because no single test confirms CBD, an important part of diagnosis is systematically excluding other explanations:

  • Blood tests – to rule out treatable causes of movement or cognitive symptoms, such as thyroid dysfunction or vitamin deficiencies
  • DaTscan – in some cases used to assess dopamine transporter function, though this doesn’t specifically distinguish CBD from other atypical parkinsonian conditions on its own
  • Trial of levodopa – CBD symptoms characteristically show minimal or no meaningful improvement with levodopa, unlike typical Parkinson’s disease; this response (or lack of it) is itself diagnostically informative

Why an Accurate Diagnosis Still Matters

Given that CBD currently has no disease-modifying treatment and diagnosis can’t be made with absolute certainty during life, some patients and families understandably ask why pursuing a thorough diagnostic workup matters. A few reasons:

  • Appropriate symptom management – knowing it’s CBD rather than typical Parkinson’s prevents prolonged, ineffective trials of standard Parkinson’s medications at escalating doses
  • Realistic expectations and planning – CBD’s typical progression differs from Parkinson’s, and accurate diagnosis allows families to plan care and support appropriately
  • Clinical trial eligibility – an accurate diagnosis is necessary for patients who wish to participate in research studies specifically targeting CBD or related tauopathies
  • Ending the search for answers – for many families, simply having a clear, well-reasoned diagnosis, even one without a cure provides genuine value after a period of uncertainty

What to Expect From the Diagnostic Process

Reaching a confident CBD diagnosis is rarely a single-visit process. It typically involves an initial detailed evaluation, imaging, sometimes neuropsychological testing, and importantly follow-up over time, since the characteristic pattern of CBD often becomes clearer as the disease progresses and other explanations are ruled out along the way.

If you or a family member has asymmetric movement symptoms, particularly involving apraxia or a limb that seems to act independently, alongside limited response to standard Parkinson’s treatment, a thorough evaluation by a movement disorder specialist is the appropriate next step.

Experiencing asymmetric movement symptoms or an unclear diagnosis?
An accurate, thorough evaluation is the first step toward the right care plan. Book a consultation with Dr. Mitesh Chandarana, one of the best movement disorder specialists in Ahmedabad.

Authoritative References

Share the Post:

Related Posts

Trusted Neurologist & Fellowship-Trained Movement Disorder Specialist

Dr. Mitesh Chandarana

Dr. Mitesh Chandarana is a highly experienced neurologist, specializing in Parkinson’s disease and movement disorders. With over 10 years of experience in neurology and 5+ years dedicated to movement disorders, he combines deep clinical knowledge with advanced treatment approaches like Botulinum Toxin Therapy and Deep Brain Stimulation (DBS).

He completed his prestigious Post-Doctoral Fellowship in Movement Disorders from Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum — one of India’s most renowned neurological institutes.

Read More >>>

“Every patient deserves accurate diagnosis, advanced care, and hope. My goal is to bring that to every consultation.”